Literature DB >> 27149102

Secretory Leukocyte Protease Inhibitor Expression and High-Risk HPV Infection in Anal Lesions of HIV-Positive Patients.

Alcina F Nicol1, Laurie L Brunette2, Gerard J Nuovo3, Beatriz Grinsztejn1, Ruth K Friedman1, Valdiléa G Veloso1, Cynthia B Cunha4, José R Coutinho1, Cecilia Vianna-Andrade1, Nathalia S Oliveira1, Andrew W Woodham2, Diane M DA Silva2, W Martin Kast2.   

Abstract

OBJECTIVE: The aim of this study was to evaluate secretory leukocyte protease inhibitor (SLPI) expression in anal biopsies from HIV-positive (HIV+) individuals, and compare that to anal intraepithelial neoplasia (AIN) diagnoses and human papillomavirus (HPV) status.
DESIGN: This is a cross-sectional study of a cohort of 54 HIV+ (31 males and 23 females) from an AIDS clinic in Rio de Janeiro, Brazil.
METHODS: The study material consisted of anorectal tissue biopsies obtained from HIV+ subjects, which were used to construct tissue microarray paraffin blocks for immunohistochemical analysis of SLPI expression. Biopsies were evaluated by an expert pathologist and classified as low-grade AIN1, high-grade AIN2/3, or normal squamous epithelium. In addition, DNA from the biopsies was extracted and analyzed for the presence of low- or high-risk HPV DNA.
RESULTS: Histologically, normal squamous epithelium from the anorectal region showed strong positive SLPI staining in 17/20 (85%) samples. In comparison, 9/17 (53%) dysplastic squamous epithelial samples from AIN1 patients showed strong SLPI staining, and only 5/17 (29%) samples from AIN2/3 patients exhibited strong SPLI staining, which both were significantly fewer than those from normal tissue (P = 0.005). Furthermore, there was a significantly higher proportion of samples in which oncogenic high-risk HPV genotypes were detected in low SLPI-expressing tissues than that in tissues with high SLPI expression (P = 0.040).
CONCLUSIONS: Taken together these results suggest that low SLPI expression is associated with high-risk HPV infections in the development of AIN.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27149102      PMCID: PMC4981526          DOI: 10.1097/QAI.0000000000001049

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  45 in total

1.  Improved amplification of genital human papillomaviruses.

Authors:  P E Gravitt; C L Peyton; T Q Alessi; C M Wheeler; F Coutlée; A Hildesheim; M H Schiffman; D R Scott; R J Apple
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

2.  Expression of the secretory leukoprotease inhibitor gene in epithelial cells.

Authors:  T Abe; N Kobayashi; K Yoshimura; B C Trapnell; H Kim; R C Hubbard; M T Brewer; R C Thompson; R G Crystal
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

3.  Cervical inflammation and immunity associated with hormonal contraception, pregnancy, and HIV-1 seroconversion.

Authors:  Charles Morrison; Raina N Fichorova; Chris Mauck; Pai-Lien Chen; Cynthia Kwok; Tsungai Chipato; Robert Salata; Gustavo F Doncel
Journal:  J Acquir Immune Defic Syndr       Date:  2014-06-01       Impact factor: 3.731

Review 4.  Anal intraepithelial neoplasia in HIV positive people.

Authors:  F Martin; M Bower
Journal:  Sex Transm Infect       Date:  2001-10       Impact factor: 3.519

Review 5.  Proteases essential for human influenza virus entry into cells and their inhibitors as potential therapeutic agents.

Authors:  Hiroshi Kido; Yuushi Okumura; Hiroshi Yamada; Trong Quang Le; Mihiro Yano
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116

6.  Salivary secretory leukocyte protease inhibitor increases in HIV infection.

Authors:  Alan L Lin; Dorthea A Johnson; Kevin T Stephan; Chih-Ko Yeh
Journal:  J Oral Pathol Med       Date:  2004-08       Impact factor: 4.253

7.  In situ detection of PCR-amplified HIV-1 nucleic acids and tumor necrosis factor cDNA in cervical tissues.

Authors:  G J Nuovo; A Forde; P MacConnell; R Fahrenwald
Journal:  Am J Pathol       Date:  1993-07       Impact factor: 4.307

8.  Estimation and comparison of salivary secretory leukocyte protease inhibitor in human immunodeficiency virus patients and healthy individuals.

Authors:  Kumar Pushpanshu; Ramhari S Sathawane; Rachna Kaushik
Journal:  Indian J Palliat Care       Date:  2014-01

9.  Human papillomavirus infection in head and neck cancer: the role of the secretory leukocyte protease inhibitor.

Authors:  Markus Hoffmann; Elgar S Quabius; Silke Tribius; Lena Hebebrand; Tibor Görögh; Gordana Halec; Tomas Kahn; Jürgen Hedderich; Christoph Röcken; Jochen Haag; Tim Waterboer; Markus Schmitt; Anna R Giuliano; W Martin Kast
Journal:  Oncol Rep       Date:  2013-03-05       Impact factor: 3.906

Review 10.  HPV infection, anal intra-epithelial neoplasia (AIN) and anal cancer: current issues.

Authors:  Margaret A Stanley; David M Winder; Jane C Sterling; Peter K C Goon
Journal:  BMC Cancer       Date:  2012-09-08       Impact factor: 4.430

View more
  5 in total

Review 1.  Human Immunodeficiency Virus Immune Cell Receptors, Coreceptors, and Cofactors: Implications for Prevention and Treatment.

Authors:  Andrew W Woodham; Joseph G Skeate; Adriana M Sanna; Julia R Taylor; Diane M Da Silva; Paula M Cannon; W Martin Kast
Journal:  AIDS Patient Care STDS       Date:  2016-07       Impact factor: 5.078

2.  Distribution and factors associated with salivary secretory leukocyte protease inhibitor concentrations.

Authors:  S Rahman; C M Pierce Campbell; B N Torres; M T O'Keefe; D J Ingles; L L Villa; R J Carvalho da Silva; R C Cintra; E Lazcano-Ponce; J Salmeron; M Quiterio; A R Giuliano
Journal:  Oral Dis       Date:  2016-08-17       Impact factor: 3.511

3.  Cervico-vaginal self-collection in HIV-infected and uninfected women from Tapajós region, Amazon, Brazil: High acceptability, hrHPV diversity and risk factors.

Authors:  Luana L S Rodrigues; Mariza G Morgado; Vikrant V Sahasrabuddhe; Vanessa S De Paula; Nathália S Oliveira; Elena Chavez-Juan; Diane M Da Silva; W Martin Kast; Alcina F Nicol; José H Pilotto
Journal:  Gynecol Oncol       Date:  2018-08-04       Impact factor: 5.482

4.  Syndemic synergy of HPV and other sexually transmitted pathogens in the development of high-grade anal squamous intraepithelial lesions.

Authors:  Jenny C McCloskey; W Martin Kast; James P Flexman; Dugald McCallum; Martyn A French; Michael Phillips
Journal:  Papillomavirus Res       Date:  2017-11-07

5.  Smoking-Induced SLPI Expression Hinders HPV Infections Also in Squamous Cell Carcinomas of the Vulva.

Authors:  Elgar S Quabius; Julius Loehr; Dirk Haaser; Veronika Günther; Nico Maass; Christoph Röcken; Micaela Mathiak; Ibrahim Alkatout; Markus Hoffmann
Journal:  Transl Oncol       Date:  2018-09-26       Impact factor: 4.243

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.